Takeaways from the course:

• To review the concept of persistent cardiovascular risk in high-risk patients on statin therapy
• Statin agents I used to reduce cardiovascular risk, however, the concept of whether there is a persistent residual risk beyond LDL lowering would be explored. 
• To explore the role of serum triglycerides as a marker of risk
• Typically, LDL cholesterol is using a marker of assessing cardiovascular risk.  His presentation explores whether serum triglycerides also serve as a marker for cardiovascular risk.
• To discuss the practical applications of icosapent ethyl for CV risk reduction